Published in Vaccine on August 31, 2006
Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination. J Natl Cancer Inst (2008) 3.33
Modeling cervical cancer prevention in developed countries. Vaccine (2008) 1.61
Calibration methods used in cancer simulation models and suggested reporting guidelines. Pharmacoeconomics (2009) 1.48
Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination. Popul Health Metr (2007) 1.39
Alternative strategies to reduce maternal mortality in India: a cost-effectiveness analysis. PLoS Med (2010) 1.20
Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results. Int J Cancer (2009) 1.06
Cost-effectiveness of treatment and endoscopic surveillance of precancerous lesions to prevent gastric cancer. Cancer (2010) 1.01
A health services research agenda for cellular, molecular and genomic technologies in cancer care. Public Health Genomics (2009) 1.01
An updated natural history model of cervical cancer: derivation of model parameters. Am J Epidemiol (2014) 0.99
Pediatric Hodgkin lymphoma: trade-offs between short- and long-term mortality risks. Blood (2012) 0.93
Model-based analyses to compare health and economic outcomes of cancer control: inclusion of disparities. J Natl Cancer Inst (2011) 0.89
Comparative evaluation of the potential impact of rotavirus versus HPV vaccination in GAVI-eligible countries: a preliminary analysis focused on the relative disease burden. BMC Infect Dis (2011) 0.88
Development, calibration, and validation of a U.S. white male population-based simulation model of esophageal adenocarcinoma. PLoS One (2010) 0.87
Assessing health and economic outcomes of interventions to reduce pregnancy-related mortality in Nigeria. BMC Public Health (2012) 0.84
Cost-Effectiveness Evaluation of Quadrivalent Human Papilloma Virus Vaccine for HPV-Related Disease in Iran. Iran J Pharm Res (2014) 0.83
Population-based type-specific prevalence of high-risk human papillomavirus infection in Estonia. BMC Infect Dis (2010) 0.82
Prophylactic HPV vaccines. J Clin Pathol (2007) 0.80
Dealing with Time in Health Economic Evaluation: Methodological Issues and Recommendations for Practice. Pharmacoeconomics (2015) 0.80
A design process for using normative models in shared decision making: a case study in the context of prenatal testing. Health Expect (2012) 0.75
Applying a Simple Model of Cost Effectiveness Study of HPV Vaccine for Iran. Iran J Pharm Res (2015) 0.75
Evidence-based policy choices for efficient and equitable cervical cancer screening programs in low-resource settings. Cancer Med (2017) 0.75
Sexual mixing patterns and sex-differentials in teenage exposure to HIV infection in rural Zimbabwe. Lancet (2002) 7.64
HIV decline associated with behavior change in eastern Zimbabwe. Science (2006) 6.98
Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med (2005) 6.72
Effect of concurrent sexual partnerships on rate of new HIV infections in a high-prevalence, rural South African population: a cohort study. Lancet (2011) 5.58
Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease. Ann Intern Med (2013) 3.83
An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull World Health Organ (2008) 3.62
Host immunity and synchronized epidemics of syphilis across the United States. Nature (2005) 3.34
Effects of unconditional and conditional cash transfers on child health and development in Zimbabwe: a cluster-randomised trial. Lancet (2013) 2.98
Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study. PLoS Med (2011) 2.76
A systematic review and meta-analysis of quantitative interviewing tools to investigate self-reported HIV and STI associated behaviours in low- and middle-income countries. Int J Epidemiol (2010) 2.59
Impact and process evaluation of integrated community and clinic-based HIV-1 control: a cluster-randomised trial in eastern Zimbabwe. PLoS Med (2007) 2.56
Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study. PLoS One (2012) 2.09
New protease inhibitors for the treatment of chronic hepatitis C: a cost-effectiveness analysis. Ann Intern Med (2012) 1.96
Concurrent sexual partnerships and primary HIV infection: a critical interaction. AIDS Behav (2011) 1.95
Handheld computers for self-administered sensitive data collection: a comparative study in Peru. BMC Med Inform Decis Mak (2008) 1.82
Palm oil taxes and cardiovascular disease mortality in India: economic-epidemiologic model. BMJ (2013) 1.81
Cost-effectiveness of helicopter versus ground emergency medical services for trauma scene transport in the United States. Ann Emerg Med (2013) 1.74
Beer halls as a focus for HIV prevention activities in rural Zimbabwe. Sex Transm Dis (2005) 1.72
Cost-effectiveness of HPV 16, 18 vaccination in Brazil. Vaccine (2007) 1.71
Patterns of movement and risk of HIV infection in rural Zimbabwe. J Infect Dis (2005) 1.62
Critique of early models of the demographic impact of HIV/AIDS in sub-Saharan Africa based on contemporary empirical data from Zimbabwe. Proc Natl Acad Sci U S A (2007) 1.58
Sex with stitches: assessing the resumption of sexual activity during the postcircumcision wound-healing period. AIDS (2012) 1.54
The future of the HIV pandemic. Bull World Health Organ (2005) 1.50
Patterns of self-reported behaviour change associated with receiving voluntary counselling and testing in a longitudinal study from Manicaland, Zimbabwe. AIDS Behav (2009) 1.41
Cost-Effectiveness of Adding Cardiac Resynchronization Therapy to an Implantable Cardioverter-Defibrillator Among Patients With Mild Heart Failure. Ann Intern Med (2015) 1.39
Chapter 19: Cost-effectiveness of cervical cancer screening. Vaccine (2006) 1.27
The epidemiological and control implications of HIV transmission probabilities within partnerships. Sex Transm Dis (2002) 1.17
Measuring and correcting biased child mortality statistics in countries with generalized epidemics of HIV infection. Bull World Health Organ (2010) 1.17
Trade-offs in cervical cancer prevention: balancing benefits and risks. Arch Intern Med (2008) 1.15
The cost-effectiveness of syndromic management in pharmacies in Lima, Peru. Sex Transm Dis (2003) 1.15
Understanding the modes of transmission model of new HIV infection and its use in prevention planning. Bull World Health Organ (2012) 1.14
Cost-effectiveness analysis of risk-factor guided and birth-cohort screening for chronic hepatitis C infection in the United States. PLoS One (2013) 1.14
Patterns of uptake of HIV testing in sub-Saharan Africa in the pre-treatment era. Trop Med Int Health (2012) 1.10
Screening and rapid molecular diagnosis of tuberculosis in prisons in Russia and Eastern Europe: a cost-effectiveness analysis. PLoS Med (2012) 1.04
Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease. J Am Coll Cardiol (2013) 1.03
Evaluating the proximate determinants framework for HIV infection in rural Zimbabwe. Sex Transm Infect (2007) 1.00
Sofosbuvir-based treatment regimens for chronic, genotype 1 hepatitis C virus infection in U.S. incarcerated populations: a cost-effectiveness analysis. Ann Intern Med (2014) 0.99
Cost effectiveness of fibrosis assessment prior to treatment for chronic hepatitis C patients. PLoS One (2011) 0.98
Diabetes, its treatment, and catastrophic medical spending in 35 developing countries. Diabetes Care (2012) 0.96
Increasing adolescent HIV prevalence in Eastern Zimbabwe--evidence of long-term survivors of mother-to-child transmission? PLoS One (2013) 0.96
Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts. Vaccine (2006) 0.94
Chapter 29: Knowledge gaps and priorities for research on prevention of HPV infection and cervical cancer. Vaccine (2006) 0.92
Multi-Country analysis of palm oil consumption and cardiovascular disease mortality for countries at different stages of economic development: 1980-1997. Global Health (2011) 0.91
The clinical interpretation of viral blips in HIV patients receiving antiviral treatment: are we ready to infer poor adherence? J Acquir Immune Defic Syndr (2012) 0.91
Did national HIV prevention programs contribute to HIV decline in Eastern Zimbabwe? Evidence from a prospective community survey. Sex Transm Dis (2011) 0.90
Monitoring trends in HIV prevalence among young people, aged 15 to 24 years, in Manicaland, Zimbabwe. J Int AIDS Soc (2011) 0.88
Cost-effectiveness of treatment of diabetic macular edema. Ann Intern Med (2014) 0.88
Mental health services use by children investigated by child welfare agencies. Pediatrics (2012) 0.86
The business case for quality improvement: oral anticoagulation for atrial fibrillation. Circ Cardiovasc Qual Outcomes (2011) 0.86
Suppressive valacyclovir therapy: impact on the population spread of HSV-2 infection. Sex Transm Dis (2007) 0.86
Self-medication prevalence for sexually transmitted diseases: meta-analysis and meta-regression of population level determinants. Sex Transm Dis (2009) 0.85
Introduction to recent developments in HIV epidemic modeling. Curr Opin HIV AIDS (2011) 0.84
Screening with OGTT alone or in combination with the Indian diabetes risk score or genotyping of TCF7L2 to detect undiagnosed type 2 diabetes in Asian Indians. Indian J Med Res (2011) 0.81
Cost-Effectiveness of HIV Preexposure Prophylaxis for People Who Inject Drugs in the United States. Ann Intern Med (2016) 0.80
Superinfection with a heterologous HIV strain per se does not lead to faster progression. Math Biosci (2009) 0.79
Could better tolerated HIV drug regimens improve patient outcome? AIDS (2012) 0.79
Accounting for biases when linking empirical studies and simulation models. Med Decis Making (2012) 0.77
Assessing screening policies for childhood obesity. Obesity (Silver Spring) (2012) 0.77
Studying complex interactions among determinants of healthcare-seeking behaviours: self-medication for sexually transmitted infection symptoms in female sex workers. Sex Transm Infect (2010) 0.77
Condom use by female sex workers and their clients in Mexico: who decides and does it matter? Sex Transm Infect (2011) 0.76
Promising control of genital warts: but is elimination possible? Lancet Infect Dis (2011) 0.76
Cost-effectiveness of preoperative imaging for appendicitis after indeterminate ultrasonography in the second or third trimester of pregnancy. Obstet Gynecol (2013) 0.76
Prioritizing guideline-recommended interventions. Ann Intern Med (2013) 0.75
Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease. Ann Intern Med (2014) 0.75
U.K. immigrant screening is inversely related to regional tuberculosis burden. Thorax (2011) 0.75
Papanicolaou screening in developing countries. Am J Clin Pathol (2005) 0.75
Antiretroviral treatment is a behavioural intervention: but why? AIDS (2010) 0.75
Analyzing Screening Policies for Childhood Obesity. Manage Sci (2013) 0.75
Knowledge-based errors in anesthesia: a paired, controlled trial of learning and retention. Can J Anaesth (2008) 0.75